IKS04 Regimen in Advanced Solid Tumors That Express CA242

NCT07738939 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Gastro Esophageal Junctional Cancer
Gastric Cancer (GC)
GEJ Adenocarcinoma
PDAC - Pancreatic Ductal Adenocarcinoma
Biliary Tract Cancer (BTC)
Gall Bladder Cancer
Cholangiocarcinoma

Interventions

DRUG: IKS04 antibody drug conjugate ADC + Isumab04 monoclonal antibody

Sponsor

Iksuda Therapeutics Ltd.